Transworld Pharma (Madras) Private Limited - Company Profile

It is a pharma private limited company based in Chennai, Tamil Nadu, India, established in 1985.
1985 Chennai, Tamil Nadu, India Active
Last Updated:
Access Report
About Transworld Pharma (Madras) Private Limited

Transworld Pharma (Madras) Private Limited, a active private limited company, was established on 23 February 1985 in Chennai, Tamil Nadu, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24239TN1985PTC067397. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹2.50 M.

It upholds a compliant status. Employing 8 professional, Its leadership includes Sengutuvan Venkataachalam (Director), Ramachandran Thillainayagam (Director). Past directors included Sivakumar Narasimhan, Shakila Sivakumar, Prabha. It holds no open charges and ₹4.00 Cr settled loans. Its latest AGM occurred on 17 September 2024, with the balance sheet filed on 31 March 2024. It is based at 29, Letangs Road Vepery, Chennai, Tamil Nadu, 600007.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239TN1985PTC067397

  • Registration Number

    067397

  • Incorporation Date

    23 February 1985

  • Authorized Capital

    ₹2.50 M

  • Paid-Up Capital

    ₹2.50 M

  • ROC Code

    Roc Chennai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.50 M
  • Paid Up Capital ₹ 2.50 M
  • Company Age 40 Year, 11 Months
  • Last Filing with ROC 31 Mar 2024
  • Satisfied Charges ₹ 4.00 Cr
  • Revenue Growth **** -11.27%
  • Profit Growth **** -1.45%
  • Ebitda **** -0.53%
  • Net Worth 26.30%
  • Total Assets -6.25%
Company report

Transworld Pharma (Madras) Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Transworld Pharma (Madras) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Transworld Pharma (Madras) Private Limited?
Current Directors
Name Designation Appointment Date Status
Sengutuvan Venkataachalam Director 25 Apr 2013 Current
Ramachandran Thillainayagam Director 25 Apr 2013 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Managing Director 22 Mar 2010 Past
Pramod Abcsdd Director 22 Mar 2010 Past
Pramod Abcsdd Director 11 Feb 2012 Past
Pramod Abcsdd Director 24 Apr 2013 Past
Pramod Abcsdd Managing Director 21 Sep 2009 Past
Pramod Abcsdd Managing Director 11 Feb 2012 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Transworld Pharma (Madras).

Transworld Pharma (Madras) Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 11.27% decrease. The company also saw a slight decrease in profitability, with a 1.45% decrease in profit. The company's net worth Soared by an impressive increase of 26.3%.

Transworld Pharma (Madras) revenue growth over time
Transworld Pharma (Madras) profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -11.27%
*******
*******
*******
*******
Revenue from Operations
*******
 -11.27%
*******
*******
*******
*******
Total Assets
*******
 -6.25%
*******
*******
*******
*******
Profit or Loss
*******
 -1.45%
*******
*******
*******
*******
Net Worth
*******
 26.30%
*******
*******
*******
*******
EBITDA
*******
 -0.53%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Transworld Pharma (Madras)?

In 2020, Transworld Pharma (Madras) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹40,000,000.00

Charges Breakdown by Lending Institutions
  • Citibank N. A. : 1.80 Cr
  • Union Bank Of India : 1.45 Cr
  • Citibank N.A : 0.35 Cr
  • Standard Chartered Bank : 0.25 Cr
  • Canar Bank : 0.15 Cr
Latest Charge Details
Date Lender Amount Status
21 Feb 2013 Citibank N. A. ₹1.80 Cr Satisfied
06 Jul 2009 Union Bank Of India ₹1.45 Cr Satisfied
28 Jun 2007 Citibank N.A ₹3.50 M Satisfied
10 Jan 2003 Standard Chartered Bank ₹2.50 M Satisfied
05 Jun 1996 Canar Bank ₹1.50 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Transworld Pharma (Madras)?

Transworld Pharma (Madras) has a workforce of 8 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Transworld Pharma (Madras), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Transworld Pharma (Madras)'s trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Transworld Pharma (Madras)
Recent Activity within the Organization
  • Annual General Meeting

    Transworld Pharma (Madras) Private Limited last Annual general meeting of members was held on 17 Sep 2024 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Transworld Pharma (Madras) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was recorded as a recent event.

  • Charges

    The activity A charge registered on 21 Feb 2013 via Charge ID 10407758 with Citibank N. A. was fully satisfied on 29 Jan 2018. was completed.

  • Director Appointment

    The activity Sengutuvan Venkataachalam was appointed as a Director was appointed as a Director on 25 Apr 2013 & has been associated with this company since 12 years 9 months . was completed.

  • Director Appointment

    Ramachandran Thillainayagam was appointed as a Director was appointed as a Director on 25 Apr 2013 & has been associated with this company since 12 years 9 months . was recorded as a recent event.

  • Charges

    Progress on A charge with Citibank N. A. amounted to Rs. 18.00 M with Charge ID 10407758 was registered on 21 Feb 2013. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Transworld Pharma (Madras) Private Limited?

The CIN of Transworld Pharma (Madras) Private Limited is U24239TN1985PTC067397.

Where is Transworld Pharma (Madras) Private Limited headquartered?

Transworld Pharma (Madras) Private Limited is headquartered at 29, Letangs Road Vepery, Chennai, Tamil Nadu, 600007.

When was Transworld Pharma (Madras) Private Limited incorporated?

Transworld Pharma (Madras) Private Limited was incorporated on 23 February 1985.

Who are the current directors of Transworld Pharma (Madras) Private Limited?

The current directors of Transworld Pharma (Madras) Private Limited are

What is the primary industry of Transworld Pharma (Madras) Private Limited?

The primary industry of Transworld Pharma (Madras) Private Limited is Trade.

Is Transworld Pharma (Madras) Private Limited a listed company?

Transworld Pharma (Madras) Private Limited is unlisted.

What is the capital structure of Transworld Pharma (Madras) Private Limited?

The authorized capital of Transworld Pharma (Madras) Private Limited is ₹2.50 M, and the paid-up capital is ₹2.50 M.

What is the compliance status of Transworld Pharma (Madras) Private Limited?

The compliance status of Transworld Pharma (Madras) Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available